Natalia Albuquerque Rocha

Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach

S. Verma, D. McGuire, Kershaw V. Patel, 2018, Current Diabetes Reports.

SGLT2 inhibition and heart failure—current concepts

A. Durães, L. Roever, M. Abreu, 2018, Heart Failure Reviews.

Impact of empagliflozin in patients with diabetes and heart failure.

Darren K Mcguire, I. Neeland, Natalia Albuquerque Rocha, 2017, Trends in cardiovascular medicine.

SGLT2 inhibition and heart failure—current concepts

A. Durães, L. Roever, M. Abreu, 2018, Heart Failure Reviews.